National Consultation on the Outcomes of the “Survey of Indian Pharmaceutical Enterprises for Meeting National and Global Health Needs
24 November 2017, New Delhi, India
WHO Country Office for India is organizing a national consultation on outcomes of ‘Survey of Indian Pharmaceutical Enterprises for Meeting National and Global Health Needs’ on 24 November 2017 at Hotel Taj Mahal, One-Mansingh Road, New Delhi.
The objectives of the consultation are to: (i) disseminate the report of the pharmaceutical survey (ii) seek inputs of various stakeholders to help guide policy interventions, and (iii) identify specific areas of support by different ministries of Government of India and WHO.
The consultation is expected to be attended by senior ministry officials, state drug controllers, Central Drugs Standard Control Organization officials and experts from Ministry of Health & Family Welfare, Department of Pharmaceuticals, Ministry of Commerce and Industry, Ministry of Micro, Small and Medium Enterprises, Department of Industrial Policy and Promotion (DIPP), NITI Aayog among others.
Several eminent experts, representatives from pharmaceutical enterprises involved in survey, and medical devices and pharmaceutical associations representatives will be participating in the deliberations.